ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2716

A New Score to Predict Digital Ulcers Combining Clinical Data, Imaging and Patient History in Systemic Sclerosis

Stefanie Friedrich1,2, Susanne Lueders3, Gerd R. Burmester4, Gabriela Riemekasten5 and Sarah Ohrndorf4, 1Department of of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin; Germany, Berlin, Germany, 2Department of Radiology, Charité University Hospital, Berlin; Germany, Berlin, Germany, 3Department of Gastroenterology and Rheumatology, Charité Universitätsmedizin Berlin, Berlin, Germany, 4Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany, 5Rheumatology, University Hospital Schleswig-Holstein - Campus Lübeck, Lübeck, Germany

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Doppler ultrasound, nailfold capillaroscopy, skin, systemic sclerosis and ulcers

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Sclerosis and Related Disorders – Clinical Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Ischemic complications such as digital ulcers (DU) are a common complication in systemic sclerosis (SSc) patients. The aim of this study was to combine clinical characteristics and imaging methods to a composite predictive score.

Methods: Seventy-nine SSc patients received clinical examination and their patient history was taken. Furthermore, we performed nailfold capillaroscopy (NC), colour Doppler ultrasonography (CDUS) and fluorescence optical imaging (FOI) of the hands at baseline. Newly developed digital ulcers over a period of approximately 12 months were registered. We used criteria with significant (p<0.5) OR values above 3.5 in regard to the development of these new DU to create the score (CIP-DUS, clinical features, imaging, patient history – digital ulcer score).

Results: Twenty-nine percent of the patients developed new DU during follow-up (48.1% diffuse SSc, 18.4% limited SSc). The following criteria were used: SSc diffuse subtype (OR 4.127, p=0.0087), modified Rodnan skin score > 8 (OR 9.429 [95%CI: 3.0-29.2], p < 0.0001), pulmonary arterial hypertension (OR 6.854 [95%CI: 1.6-9.7], p = 0.0088), present digital ulcers or pitting scars at baseline (OR 15.71 [95%CI: 3.3-74.3], p < 0.0001), history of digital ulcer or pitting scars (OR 36.15 [95%CI: 2.1-626.9], p < 0.0001), NC pattern (OR 18.6 [95%CI: 1.1-326.4], p = 0.0035), reduced capillary density (n < 7/mm) in digit III of the right hand in NC (OR 9.0 [95%CI: 1.1-73.6], p = 0.0266), missing initial enhancement in FOI in digit III of the right hand (OR 3.857 [95%CI: 1.2-12.8], p = 0.0323), percentage of pathologic (i. e. narrowed or occluded) vessels > 35% in CDUS (OR 4.286 [95%CI: 1.5-12.4], p = 0.0099). Criteria with greater OR should impact the score to a higher degree so we appointed three points to dichotomous criteria with OR > 10, two points for criteria with OR between 5-10, and one point for criteria with OR < 5. Regarding the NC pattern, 3 points were given to patients with late pattern, 2 points for active and 1 point for early pattern. Best results were found for a cut-off of >10 points with obtained sensitivity levels of 95% and specificity levels of 74% in regard to new DU (AUC = 0.8687, p < 0.0001). In the absence of CDUS and FOI data, specificity levels dropped slightly to 72% with unchanged sensitivity values of 95%.

Conclusion: A new score was introduced with the aim to predict digital ulcers. If applied correctly and with the new imaging techniques proposed, 95% of patients at risk of digital ulcers throughout 12 months could be identified.


Disclosure: S. Friedrich, None; S. Lueders, None; G. R. Burmester, None; G. Riemekasten, None; S. Ohrndorf, None.

To cite this abstract in AMA style:

Friedrich S, Lueders S, Burmester GR, Riemekasten G, Ohrndorf S. A New Score to Predict Digital Ulcers Combining Clinical Data, Imaging and Patient History in Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/a-new-score-to-predict-digital-ulcers-combining-clinical-data-imaging-and-patient-history-in-systemic-sclerosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-new-score-to-predict-digital-ulcers-combining-clinical-data-imaging-and-patient-history-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology